Table 2.
SAM | TZP | CAZ | FEM | AMK | GAT | TOB | NET | CIPX | TGC | CST | SXT | IPM | MEM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sensitive n (%) | 8 (7.3) | 3 (2.8) | 19 (17.4) | 2 (1.7) | 19 (17.4) | 85 (77.9) | 86 (78.9) | 93 (85.3) | 2 (1.8) | 109 (100) | 109 (100) | 69 (63.3) | 7 (6.4) | 6 (5.5) |
Intermediate n (%) | 22 (20.2) | 0 | 7 (6.4) | 1 (1.1) | 4 (3.7) | 3 (2.8) | 0 | 1 (1.0) | 0 | 0 | 0 | 0 | 2 (1.7) | 1 (1.0) |
Resistant n (%) | 79 (72.5) | 106 (97.2) | 83 (76.2) | 106 (97.2) | 86 (78.9) | 21 (19.3) | 23 (21.1) | 15 (13.7) | 107 (98.2) | 0 | 0 | 40 (36.7) | 100 (91.9) | 102 (93.5) |
bla OXA-51-like | All isolates (n=109) were positive | |||||||||||||
bla OXA-23-like | 103 of isolates were positive | |||||||||||||
bla OXA-24-like | All negative | |||||||||||||
bla OXA-48-like | All negative | |||||||||||||
bla OXA-58-like | All negative |
SAM: Ampicillin-sulbactam, TZP: Piperacillin-tazobactam, CAZ: Ceftazidime, FEM: Cefepime, AMK: Amikacin, GAT: Gentamicin, TOB: Tobramicin, NET: Netilmicin.
TGC: Tigecycline, CIPX(Ciprofloxacin),CST: Colistin, SXT: Trimethoprim-sulphamethoxazole, IPM: Imipenem, MEM: Meropenem.